A significant increment of CD8+ T‐cell infiltration into the tumor was also seen on day 8 following treatment with nanoSTING@Mn compared to STING alone (3.2‐fold; p < 0.0001) or nanoSTING (1.9‐fold; p < 0.0001) (Figure 1E). The gene discussed is STING1; the disease is neoplasm.